The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S.
W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...
Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.
Luxury cruise retailer Panache Cruises is embarking on further international expansion after agreeing a £2.75m refinance package with HSBC UK. The company intends to open up new offices in Canada and ...
Listen, life can be rough and some of the most comfort and safety we can feel is with an animal of our own. Whether it be cats, dogs, birds, guinea pigs, horses, ferrets… having another living ...
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...
Eve was one of dozens of Thai women who traveled 4,000 miles — only to be trapped by the dark side of the global fertility industry. Credit...Illustration by Nicole Rifkin Supported by By Sarah A.
Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback